Memphasys Limited (ASX:MEM) Executive Chairman, Alison Coutts presents details on the company's trial sperm separation efficacy and the need to improve male fertility at FNN's Investor Event.
- Male infertility affects 1/3 of men over 40
- Felix - a unique device to treat male infertility
- No meaningful advances in male infertility treatments since the advent of IVF
- How the technology works
- Commercialisation opportunities
For more, watch Executive Chairman Alison Coutts present.